Enhancing Systemic Sclerosis Understanding and Management:
A Webinar Series on BSR 2024 Guidelines
Date
28 November 2024 - 16 May 2025
Moderator: Professor Christopher Denton
This is an educational webinar series organised and funded by Johnson & Johnson intended for UK HCPs only. BSR will not share any personal data with Johnson & Johnson. Date of preparation January 2025 | CP-478708
Webinar 1
Available on-demand
Title: Guidelines Overview – Scope and Purpose
Speaker: Professor Christopher Denton
Learning Objectives:
- To understand the purpose and scope of the 2024 BSR guidelines for the management of SSc.
- To identify the most important updates in the recommendations for SSc assessment, classification, and management.
- To discuss how the new recommendations can be implemented in clinical practice.
Webinar 2
Date: 15:00 - 15:30 GMT, 14 February 2025
Title: Cardiorespiratory Complications Management
Speakers: Professor Maya H Buch, Professor Elisabetta Renzoni
Learning Objectives:
- To identify and describe the cardiorespiratory complications associated with SSc, such as primary cardiac involvement (pHI) and interstitial lung disease (ILD).
- To explore the evidence-based treatment options and management strategies for cardiorespiratory complications recommended by the 2024 BSR guidelines and national policies.
Webinar 3
Date: 16:00 - 16:30 GMT, 18 March 2025
Title: Vasculopathy Manifestations in SSc
Speakers: Professor Francesco Del Galdo, Dr John Pauling
Learning Objectives:
- To recognise the vasculopathy manifestations in SSc, such as PAH, Raynaud's phenomenon and digital vasculopathy.
- To understand the impact of vasculopathy manifestations on patients’ quality of life.
- To become familiar with the available treatment options and management strategies according to the 2024 BSR guidelines.
Webinar 4
Date: 16:00 - 16:30 BST, 16 May 2025
Title: Approach to Other Manifestations in SSc
Speakers: Dr Bridget Griffiths, Dr Voon Ong
Learning Objectives:
- To recognise and understand the breadth of SSc manifestations beyond cardiorespiratory and vasculopathy complications, including renal, gastrointestinal tract, and skin manifestations, as well as calcinosis.
- To discuss practical insights on the management of these SSc manifestations and explore the implications of the 2024 BSR guideline updates on clinical practice.